• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    CytRx Corporation (CYTR)

    -NasdaqCM
    3.66 Down 0.06(1.61%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:3.72
    Open:3.72
    Bid:3.05 x 500
    Ask:4.53 x 2400
    1y Target Est:8.50
    Beta:3.54
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:3.62 - 3.77
    52wk Range:2.08 - 5.42
    Volume:297,179
    Avg Vol (3m):1,179,370
    Market Cap:203.95M
    P/E (ttm):N/A
    EPS (ttm):-0.94
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CYTRDown 1.61%203.95M
    LLYUp 1.52%91.22B
    NVSUp 1.30%241.55B
    SNYDown 0.58%129.36B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2,072.86
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.11
    Quarterly EPS Est (Jun-15) :-0.27
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate is aldoxorubicin, which is in Phase III clinical trial as a therapy for patients with soft tissue sar... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback